Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial FibrillationRecruiting
Sponsor: Bayer
Atrial Fibrillation
United States, Belgium, Bulgaria, Germany, Hungary +3 more
Sponsor: Novartis Pharmaceuticals
Non-segmental Vitiligo
United States, Argentina, Australia, Canada, China +7 more
- A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney FunctionNot Yet Recruiting
Sponsor: Novo Nordisk A/S
Chronic Kidney Disease
Germany
Sponsor: iOMEDICO AG
Waldenström's Macroglobulinemia · Chronic Lymphocytic Leukemia · Marginal Zone Lymphoma · Follicular Lymphoma
Austria, Germany
Sponsor: National Institute of Oncology, Hungary
Breast Neoplasms
France, Germany, Hungary, Lithuania, Poland +4 more
- Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresActive Not Recruiting
Sponsor: SK Life Science, Inc.
Partial Epilepsy
United States, Australia, Germany, Hungary, Poland +2 more
Sponsor: Alnylam Pharmaceuticals
Transthyretin Amyloidosis With Cardiomyopathy
United States, Germany, Japan
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Australia, Bulgaria, Canada +19 more
- NUsurface Implant RegistryTerminated
Sponsor: Phoenix Kinetics
Meniscus; Degeneration · Knee Osteoarthritis · Knee Pain Chronic
Belgium, Germany, Israel, Netherlands
Sponsor: PTC Therapeutics
Phenylketonuria
United States, Australia, Brazil, Canada, Czechia +14 more
Sponsor: Celgene
Multiple Sclerosis Spasticity
United States, Australia, Canada, Czechia, Germany +2 more
Sponsor: Merck Sharp & Dohme LLC
Colon Adenocarcinoma · Rectal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +24 more
- Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain MetastasisRecruiting
Sponsor: MedSIR
NSCLC · Brain Metastases · ROS1 Gene Rearrangement
Austria, Germany, Spain
Sponsor: MoonLake Immunotherapeutics AG
Hidradenitis Suppurativa
United States, Bulgaria, Canada, Germany, Ireland +2 more
Sponsor: Genmab
Endometrial Cancer · Recurrent or Progressive Endometrial Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Cholangiocarcinoma · Klatskin Tumor · Bile Duct Cancer · Liver Cancer
Germany
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesActive Not Recruiting
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Brazil, Bulgaria, Canada, Czechia +14 more
Sponsor: Novartis Pharmaceuticals
Advanced Solid Tumors Which Are cMET-dependent
United States, Belgium, Canada, China, Denmark +6 more
Sponsor: Insel Gruppe AG, University Hospital Bern
Ischemic Stroke · Atrial Fibrillation
Belgium, Germany, New Zealand, Spain, Switzerland +1 more
- Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case SeriesActive Not Recruiting
Sponsor: 41medical AG
Distal Femur Fracture · Periprosthetic Fractures · Intra-Articular Fractures · Supracondylar Fracture
Germany, Switzerland
- Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg EmployeesActive Not Recruiting
Sponsor: Jacobs University Bremen gGmbH
Social Isolation or Loneliness · Anxiety · Anxiety Depression (Mild or Not Persistent) · Health Behavior
Germany
Sponsor: Boehringer Ingelheim
Healthy
Germany
Sponsor: AstraZeneca
Heart Failure With Preserved Ejection Fraction (HFpEF) · Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
United States, Argentina, Australia, Austria, Brazil +27 more
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive Not Recruiting
Sponsor: Novo Nordisk A/S
Obesity
United States, Austria, Belgium, Denmark, Germany +5 more
- Long-term Extension of GTX-102 in Angelman SyndromeActive Not Recruiting
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Australia, Canada, France, Germany +3 more